News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-19 1:6:39 pm SELLAS Life Sciences Group Announces Closing of $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules GlobeNewsWire
2024-03-19 5:47:0 am SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET GlobeNewswire
2024-03-15 6:0:0 am SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules GlobeNewswire
2024-03-08 5:0:0 am SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships GlobeNewswire
2024-03-01 5:30:0 am SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Patients at 2024 European School of Haematology (ESH) Conference GlobeNewswire
2024-02-29 5:0:0 am SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference: Updated Date and Time GlobeNewswire
2024-02-06 5:30:0 am SELLAS Announces Publication of Preclinical Data on its Highly Selective CDK9 Inhibitor, SLS009, in Oncotarget GlobeNewswire
2024-01-25 5:45:0 am SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference GlobeNewswire
2024-01-10 8:30:0 am SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate Zacks
   

Please consider a small donation if you think this website provides you with relevant information